Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?
Frontiers In Endocrinology
Fanciulli, Giuseppe G; Modica, Roberta R; La Salvia, Anna A; Grossrubatscher, Erika Maria EM; Florio, Tullio T; Ferraù, Francesco F; Veresani, Alessandro A; Russo, Flaminia F; Colao, Annamaria A; Faggiano, Antongiulio A
Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes.
Cancers
Alqahtani, Tariq T; Kumarasamy, Vishnu V; Alghamdi, Sahar Saleh SS; Suliman, Rasha Saad RS; Bin Saleh, Khalid K; Alrashed, Mohammed A MA; Aldhaeefi, Mohammed M; Sun, Daekyu D
RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer.
Journal Of Translational Medicine
Wang, Chunyue C; Zhang, Zhenlong Z; Sun, Yulan Y; Wang, Song S; Wu, Mengmeng M; Ou, Qiuxiang Q; Xu, Yang Y; Chen, Zhiming Z; Shao, Yang Y; Liu, Hong H; Hou, Peifeng P
Comprehensive Assessment of Indian Variations in the Druggable Kinome Landscape Highlights Distinct Insights at the Sequence, Structure and Pharmacogenomic Stratum.
Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.
Genetic Alterations in Mitochondrial DNA Are Complementary to Nuclear DNA Mutations in Pheochromocytomas.
Cancers
Tabebi, Mouna M; Łysiak, Małgorzata M; Dutta, Ravi Kumar RK; Lomazzi, Sandra S; Turkina, Maria V MV; Brunaud, Laurent L; Gimm, Oliver O; Söderkvist, Peter P
Publication Date: 2022-01-06
Variant appearance in text: RET: 1902C>G; C634W; rs77709286
Genetic Alterations in Mitochondrial DNA Are Complementary to Nuclear DNA Mutations in Pheochromocytomas.
Cancers
Tabebi, Mouna M; Łysiak, Małgorzata M; Dutta, Ravi Kumar RK; Lomazzi, Sandra S; Turkina, Maria V MV; Brunaud, Laurent L; Gimm, Oliver O; Söderkvist, Peter P
Publication Date: 2022-01-06
Variant appearance in text: RET: 1902C>G; C634W; rs77709286
Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.
Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives.
Cancers
Fancelli, Sara S; Caliman, Enrico E; Mazzoni, Francesca F; Brugia, Marco M; Castiglione, Francesca F; Voltolini, Luca L; Pillozzi, Serena S; Antonuzzo, Lorenzo L
Comprehensive Immune Profiling of Medullary Thyroid Cancer.
Thyroid : Official Journal Of The American Thyroid Association
Pozdeyev, Nikita N; Erickson, Timothy A TA; Zhang, Lian L; Ellison, Kim K; Rivard, Christopher J CJ; Sams, Sharon S; Hirsch, Fred R FR; Haugen, Bryan R BR; French, Jena D JD
Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.
Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association
Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H
PTPRA Phosphatase Regulates GDNF-Dependent RET Signaling and Inhibits the RET Mutant MEN2A Oncogenic Potential.
Iscience
Yadav, Leena L; Pietilä, Elina E; Öhman, Tiina T; Liu, Xiaonan X; Mahato, Arun K AK; Sidorova, Yulia Y; Lehti, Kaisa K; Saarma, Mart M; Varjosalo, Markku M